◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › EUK

EuKedos S.p.A. (EUK) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-10-03

EuKedos S.p.A. (EUK) operates in the Medical Care Facilities industry and is headquartered in Florence, Italy with about 545 employees. Its market capitalization is roughly €13 million. In the fiscal year ended 2025-12-31, EUK reported €53M in revenue and (€1M) in net income.

EuKedos S.p.A. operates in the managed-care sector in Italy. It manages nursing homes. The company also offers residential and day care to independent and dependent elderly people, and disabled adults, as well as people with mild, moderate, and severe cognitive impairment and patients with psychiatric conditions.

Interactive charts & full statements → Open the EUK valuation workbench →

EUK Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€53M€52M€50M€47M—
Gross Profit€50M€49M€47M€44M—
Operating Income (EBIT)€5M€5M€5M€4M—
Net Income(€1M)(€0M)€1M€0M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUK Free Cash Flow History

EUK Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€180M€183M€149M€153M—
Total Liabilities€151M€153M€119M€124M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EUK viewer.

Other Companies in Medical Care Facilities

← EUINAll “E” companiesEUM →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.